SQSTM1 and hepatocellular carcinoma: In keeping with this evidence, Saito and colleagues demonstrated that Nrf2-activating phosphorylation of the p62 KIR domain increases chemoresistance, proliferation and malignancy of HCC, confirming the cancer protective role of p62-dependent Nrf2 activation [13].